Needle-free IV Connectors Market Develop in Designed to Reduce the Risk of infection

Needle-free IV Connectors are routinely used in the hospitals for intravenous administration of fluids and medicines to protect the central part of the vascular access systems. Needle-free IV connectors’ aids in reducing risks of possible contaminations associated with the IV administration and stop manipulation in all types of IV infusions. Moreover, technological advancements in needle-free IV connectors such as connectors preventing fluid reflux, closed IV systems, and connectors embedded with antimicrobial agents (V-Link) is expected to help to reduce the risk of bloodstream infections associated with IV administration.

Download PDF Sample Report @
https://www.coherentmarketinsights.com/insight/request-sample/426

Growing prevalence of chronic diseases with increasing need of treatment, risk of possible bloodstream infections, and effectiveness over conventional IV administration are expected to be the major factors driving growth of the global needle-free IV connectors market over the forecast period. Manufacturers are focusing on minimizing the risks associated with IV administration with conventional methods coupled with existing minor issues associated with the use of needle-free IV connectors such as blood reflux caused by gasket compression and blood reflux due to disconnection with the luer.

For instance, MicroClave connector of ICU Medical offers minimal blood reflux in the catheter tip. The company has received three type of the U.S. patents for MicroClave clear needle-free connector in 2015 and 2016. Moreover, in September 2014, RyMed Technologies developed InVision-Plus a silver-coated connector, with neutral advantage technology designed to reduce bacterial contamination. Furthermore, increasing regulatory approvals from regulatory bodies is expected to drive growth of the global needle free IV connectors market over the forecast period.

For instance, in January 2016, Hospira, a Pfizer-owned company and provider of infusion technologies, received the CE mark approval for a new needle free intravenous (IV) connector, the Nuitiv Clear Needle-free Connector. Nuitiv was launched globally, with immediate availability in Latin America, followed by Europe in early 2016. Key players are focused on developing and offering connectors for intravenous and other routes of administration. For instance, U.S. Food and Drug Administration (FDA) approved world’s first needleless connector, Tego needle-free connector used in hemodialysis applications that was developed by ICU Medical Inc. in 2014. Furthermore, Vygon S.A. launched Nutrifit enteral connectors in 2016. These are used in neonates to ensure safe and secure enteral feeding.

For Customization on this Report @ https://www.coherentmarketinsights.com/insight/request-customization/426

Major Market Competitors

Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon S.A.

Market Segmentation

Global Needle-free IV Connectors Market, By Design Type:
Straight Channel
T-channel
Y-channel
Multi-channel
Global Needle-free IV Connectors Market, By Mechanism:
Positive
Negative
Neutral
Global Needle-free IV Connectors Market, By Dwell Time:
Seven-day
Other than Seven-day
Global Needle-free IV Connectors Market, By End User:
Hospitals
Ambulatory Surgical Centers
Others

Buy This Complete A Business Report:
https://www.coherentMarketinsights.com/promo/buynow/426

Covid-19 Impact:

The COVID-19 pandemic has exacerbated the world’s healthcare challenges. Social distancing and shutdowns have accelerated adoption of digital technologies in the healthcare sector. Our updated reports have answers to various concerns in the global Needle-free IV Connectors market caused due to the pandemic.

Contact us:
Mr. Shah
Senior Client Partner – Business Development
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
sales@coherentMarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.